Cooper Companies (NASDAQ:COO) Stock Rating Lowered by Wall Street Zen

Cooper Companies (NASDAQ:COO) was downgraded by investment analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a note issued to investors on Saturday.

Several other research firms have also weighed in on COO. KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research report on Wednesday, May 27th. JPMorgan Chase & Co. reduced their price target on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Finally, Rothschild & Co Redburn cut shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $82.64.

Cooper Companies Price Performance

Shares of COO opened at $67.88 on Friday. The stock has a market cap of $13.24 billion, a P/E ratio of 57.53, a price-to-earnings-growth ratio of 1.77 and a beta of 0.87. Cooper Companies has a 1 year low of $58.89 and a 1 year high of $89.83. The stock’s 50-day moving average price is $64.79 and its two-hundred day moving average price is $74.35. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.Cooper Companies’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts predict that Cooper Companies will post 4.63 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Capital World Investors grew its holdings in shares of Cooper Companies by 25.7% during the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after buying an additional 2,159,233 shares in the last quarter. State Street Corp grew its holdings in shares of Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after buying an additional 207,195 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Cooper Companies by 58.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares in the last quarter. Finally, Sustainable Growth Advisers LP grew its holdings in shares of Cooper Companies by 22.1% during the third quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock worth $283,327,000 after buying an additional 747,476 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.